


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app29.us.archive.org';v.server_ms=732;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>ACR Appropriateness Criteria&amp;reg; cranial neuropathy. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180713042756im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180713042756im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180713042756im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180713042756im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180713042756/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180713042756im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180713042756cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180713042756js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180713042756if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180713042756/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180713042756if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180713042756/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180713042756/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180713042756/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180713042756/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180713042756im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180713042756im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180713042756/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180713042756/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180713042756/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180713042756/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180713042756/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180713042756/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180713042756/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180713042756/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180713042756/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180713042756/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180713042756/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180713042756/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180713042756/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180713042756/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180713042756/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180713042756/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180713042756/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180713042756/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180713042756/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180713042756/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180713042756/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:011203</li>
            <li>2017
            </li>            
                                        <li>
                    <div class="flag-box"><span class="neats"></span> NEATS Assessment</div>    
                    <a class="icon-info" href="/web/20180713042756/https://www.guideline.gov/help-and-about/summaries/determining-extent-adherence-to-the-iom-standards-in-ngc"><span class="screen-reader-text">Learn More About NEATS Assessment</span></a>                
                </li>
        </ul>
        <div>
                <h1>ACR Appropriateness Criteria&reg; cranial neuropathy.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
<li><a href="#neats-tab" class="NEATS"><span class="label">NEATS Assessment</span></a></li>        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180713042756/https://www.guideline.gov/search?f_Guideline_Developer_String=American%20College%20of%20Radiology&amp;fLockTerm=American%2BCollege%2Bof%2BRadiology">American College of Radiology</a></li>
                        <li>   
                                <a id="246" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Policeni B, Burns J, Conley DB, Crowley RW, Harvey HB, Hoang J, Hunt CH, Jagadeesan BD, Juliano AF, Kennedy TA, Moonis G, Pannell JS, Patel ND, Perlmutter JS, Rosenow JM, Schroeder JW, Whitehead MT, Cornelius RS, Corey AS, Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria® cranial neuropathy. Reston (VA): American College of Radiology (ACR); 2017. 22 p.  [136 references]</td></tr></table>                    <p><a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=fulltextlink&amp;redirect=https%253a%252f%252facsearch.acr.org%252fdocs%252f69509%252fNarrative%252f">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Wippold FJ II, Cornelius RS, Aiken AH, Angtuaco EJ, Berger KL, Brown DC, Davis PC, Holloway K, McConnell CT Jr, Mechtler LL, Nussenbaum B, Rosenow JM, Roth CJ, Seidenwurm DJ, Slavin K, Waxman AD, Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria&reg; cranial neuropathy. [online publication]. Reston (VA): American College of Radiology (ACR); 2012. 18 p. [130 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                            <h4>UMLS Concepts <a href="/web/20180713042756/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180713042756/https://www.guideline.gov/search?f_ICD9CM_CUI=C0011923&amp;fLockTerm=Diagnostic+imaging%2c+not+elsewhere+classified">Diagnostic imaging, not elsewhere classified</a>
 (88.90), <a href="/web/20180713042756/https://www.guideline.gov/search?f_ICD9CM_CUI=C0010266&amp;fLockTerm=Unspecified+disorder+of+cranial+nerves">Unspecified disorder of cranial nerves</a>
 (352.9)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C1536105&amp;fLockTerm=Computed+Tomography+Angiography">Computed Tomography Angiography</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0010266&amp;fLockTerm=Cranial+Nerve+Diseases">Cranial Nerve Diseases</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0011906&amp;fLockTerm=Diagnosis%2c+Differential">Diagnosis, Differential</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0011923&amp;fLockTerm=Diagnostic+Imaging">Diagnostic Imaging</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0046056&amp;fLockTerm=Fluorodeoxyglucose+F18">Fluorodeoxyglucose F18</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0243032&amp;fLockTerm=Magnetic+Resonance+Angiography">Magnetic Resonance Angiography</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0024485&amp;fLockTerm=Magnetic+Resonance+Imaging">Magnetic Resonance Imaging</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C1699633&amp;fLockTerm=Positron+Emission+Tomography+Computed+Tomography">Positron Emission Tomography Computed Tomography</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0032743&amp;fLockTerm=Positron-Emission+Tomography">Positron-Emission Tomography</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C3665494&amp;fLockTerm=Radiography%2c+Thoracic">Radiography, Thoracic</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0936234&amp;fLockTerm=Tomography+Scanners%2c+X-Ray+Computed">Tomography Scanners, X-Ray Computed</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0040405&amp;fLockTerm=Tomography%2c+X-Ray+Computed">Tomography, X-Ray Computed</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MSH_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0936234&amp;fLockTerm=Computed+Tomography+Scanning+Systems">Computed Tomography Scanning Systems</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0010266&amp;fLockTerm=Cranial+nerve+diseases">Cranial nerve diseases</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0011923&amp;fLockTerm=Diagnostic+Imaging">Diagnostic Imaging</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0043299&amp;fLockTerm=Diagnostic+radiologic+examination">Diagnostic radiologic examination</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0011906&amp;fLockTerm=Differential+Diagnosis">Differential Diagnosis</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0046056&amp;fLockTerm=Fluorodeoxyglucose+F18">Fluorodeoxyglucose F18</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0243032&amp;fLockTerm=Magnetic+Resonance+Angiography">Magnetic Resonance Angiography</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0024485&amp;fLockTerm=Magnetic+Resonance+Imaging">Magnetic Resonance Imaging</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C1699633&amp;fLockTerm=PET%2fCT+scan">PET/CT scan</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0039985&amp;fLockTerm=Plain+chest+X-ray">Plain chest X-ray</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0032743&amp;fLockTerm=Positron-Emission+Tomography">Positron-Emission Tomography</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C3665494&amp;fLockTerm=Thoracic+Radiography">Thoracic Radiography</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_MTH_CUI=C0040405&amp;fLockTerm=X-Ray+Computed+Tomography">X-Ray Computed Tomography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180713042756/https://www.guideline.gov/search?f_PDQ_CUI=C0040405&amp;fLockTerm=computed+tomography">computed tomography</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_PDQ_CUI=C0011923&amp;fLockTerm=diagnostic+imaging">diagnostic imaging</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_PDQ_CUI=C0043299&amp;fLockTerm=diagnostic+radiology">diagnostic radiology</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_PDQ_CUI=C0046056&amp;fLockTerm=fludeoxyglucose+F+18">fludeoxyglucose F 18</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_PDQ_CUI=C0024485&amp;fLockTerm=magnetic+resonance+imaging">magnetic resonance imaging</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_PDQ_CUI=C0041618&amp;fLockTerm=ultrasonography">ultrasonography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0040405&amp;fLockTerm=Computerized+axial+tomography">Computerized axial tomography</a>
 (77477000), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009924&amp;fLockTerm=Contrast+media">Contrast media</a>
 (385420005), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009924&amp;fLockTerm=Contrast+media">Contrast media</a>
 (407935004), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0010266&amp;fLockTerm=Cranial+nerve+disorder">Cranial nerve disorder</a>
 (73013002), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1536105&amp;fLockTerm=CT+angiography">CT angiography</a>
 (418272005), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011906&amp;fLockTerm=Differential+diagnosis">Differential diagnosis</a>
 (47965005), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0046056&amp;fLockTerm=Fluorodeoxyglucose+F%5e18%5e">Fluorodeoxyglucose F^18^</a>
 (35321007), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011923&amp;fLockTerm=Imaging">Imaging</a>
 (363679005), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0024485&amp;fLockTerm=Magnetic+resonance+imaging">Magnetic resonance imaging</a>
 (113091000), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0024485&amp;fLockTerm=Magnetic+resonance+imaging">Magnetic resonance imaging</a>
 (312250003), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0243032&amp;fLockTerm=Magnetic+resonance+imaging+(MRI)+of+vessels">Magnetic resonance imaging (MRI) of vessels</a>
 (241663008), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0336660&amp;fLockTerm=Magnetic+resonance+imaging+unit">Magnetic resonance imaging unit</a>
 (90003000), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C3882574&amp;fLockTerm=PET%2fCT+system">PET/CT system</a>
 (717326002), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0039985&amp;fLockTerm=Plain+chest+X-ray">Plain chest X-ray</a>
 (399208008), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032743&amp;fLockTerm=Positron+emission+tomography">Positron emission tomography</a>
 (363678002), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032743&amp;fLockTerm=Positron+emission+tomography">Positron emission tomography</a>
 (82918005), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0182349&amp;fLockTerm=Positron+emission+tomography+unit">Positron emission tomography unit</a>
 (39821008), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0182349&amp;fLockTerm=Positron+emission+tomography+unit">Positron emission tomography unit</a>
 (462323006), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1699633&amp;fLockTerm=Positron+emission+tomography+with+computed+tomography">Positron emission tomography with computed tomography</a>
 (450436003), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C3665494&amp;fLockTerm=Thoracic+cage+X-ray">Thoracic cage X-ray</a>
 (303932001), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
 (16310003), <a href="/web/20180713042756/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0041618&amp;fLockTerm=Ultrasonography">Ultrasonography</a>
 (278292003)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SPN</h5>
                    <div class="field-content">
<a href="/web/20180713042756/https://www.guideline.gov/search?f_SPN_CUI=C0302622&amp;fLockTerm=SYSTEM%2c+IMAGING%2c+PULSED+DOPPLER%2c+ULTRASONIC">SYSTEM, IMAGING, PULSED DOPPLER, ULTRASONIC</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_SPN_CUI=C0336660&amp;fLockTerm=SYSTEM%2c+NUCLEAR+MAGNETIC+RESONANCE+IMAGING">SYSTEM, NUCLEAR MAGNETIC RESONANCE IMAGING</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_SPN_CUI=C0182349&amp;fLockTerm=SYSTEM%2c+TOMOGRAPHY%2c+COMPUTED%2c+EMISSION">SYSTEM, TOMOGRAPHY, COMPUTED, EMISSION</a>
, <a href="/web/20180713042756/https://www.guideline.gov/search?f_SPN_CUI=C0936234&amp;fLockTerm=SYSTEM%2c+X-RAY%2c+TOMOGRAPHY%2c+COMPUTED">SYSTEM, X-RAY, TOMOGRAPHY, COMPUTED</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180713042756/https://www.guideline.gov/search?f_UMD_CUI=C0009924&amp;fLockTerm=Contrast+Media">Contrast Media</a>
 (16-573), <a href="/web/20180713042756/https://www.guideline.gov/search?f_UMD_CUI=C0810501&amp;fLockTerm=Radiographic+Systems%2c+Digital%2c+Chest">Radiographic Systems, Digital, Chest</a>
 (18-431), <a href="/web/20180713042756/https://www.guideline.gov/search?f_UMD_CUI=C0936234&amp;fLockTerm=Scanning+Systems%2c+Computed+Tomography">Scanning Systems, Computed Tomography</a>
 (13-469), <a href="/web/20180713042756/https://www.guideline.gov/search?f_UMD_CUI=C0336660&amp;fLockTerm=Scanning+Systems%2c+Magnetic+Resonance+Imaging">Scanning Systems, Magnetic Resonance Imaging</a>
 (16-260), <a href="/web/20180713042756/https://www.guideline.gov/search?f_UMD_CUI=C0182349&amp;fLockTerm=Scanning+Systems%2c+Positron+Emission+Tomography">Scanning Systems, Positron Emission Tomography</a>
 (16-375), <a href="/web/20180713042756/https://www.guideline.gov/search?f_UMD_CUI=C0302622&amp;fLockTerm=Scanning+Systems%2c+Ultrasonic">Scanning Systems, Ultrasonic</a>
 (14-278)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
            <div id="neats-tab" class="content-tab-panel">
                <p id="NeatsDescription">
                    National Guideline Clearinghouse (NGC) has assessed this guideline's adherence to standards of trustworthiness, derived from the Institute of Medicine's report
                    <a href="/web/20180713042756/https://www.guideline.gov/disclaimer?id=51005&amp;contentType=summary&amp;redirect=http%3A%2F%2Fnationalacademies.org%2Fhmd%2FReports%2F2011%2FClinical-Practice-Guidelines-We-Can-Trust.aspx"><i>Clinical Practice Guidelines We Can Trust</i></a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif">.
                </p>
                <div class="ratings" aria-hidden="true">
                    <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-1.png" alt="Poor"/> = Poor</span>
                    <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-2.png" alt="Fair"/> = Fair</span>
                    <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-3.png" alt="Good"/> = Good</span>
                    <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-4.png" alt="Very Good"/> = Very Good</span>
                    <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-5.png" alt="Excellent"/> = Excellent</span>
                </div>
                    <table aria-describedby="NeatsDescription">
                        <thead>
                        <tr>
                            <th id="section">NEATS Assessment <a class="icon-info" href="/web/20180713042756/https://www.guideline.gov/help-and-about/summaries/determining-extent-adherence-to-the-iom-standards-in-ngc"><span class="screen-reader-text">More about NGC's appraisal</span></a></th>
                            <th id="standard">Standard of Trustworthiness</th>
                        </tr>
                        </thead>
                        <tbody>
                                        <tr>
                    <td class="topborderme" headers="section">Yes</td>
                    <td class="greenboldme topborderme" headers="standard">Disclosure of Guideline Funding Source</td>
                </tr>
                <tr>
                    <td class="topborderme" headers="section">                <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-3.png" alt="Good"/></span>
</td>
                    <td class="greenboldme topborderme" headers="standard">Disclosure and Management of Financial Conflict of Interests</td>
                </tr>
                    <tr>
                        <td class="topborderme" id="blank"></td>
                        <th class="greenboldme topborderme" id="185" headers="standard">Guideline Development Group Composition</th>
                    </tr>
                    <tr>
                        <td headers="section">
                            Yes
                        </td>
                        <td class="leftpadme" headers="185">Multidisciplinary Group</td>
                    </tr>
                    <tr>
                        <td headers="section">
                            Yes
                        </td>
                        <td class="leftpadme" headers="186">Methodologist Involvement</td>
                    </tr>
                    <tr>
                        <td headers="section">
                                            <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-1.png" alt="Poor"/></span>

                        </td>
                        <td class="leftpadme" headers="187">Patient and Public Perspectives</td>
                    </tr>
                    <tr>
                        <td class="topborderme" id="blank"></td>
                        <th class="greenboldme topborderme" id="188" headers="standard">Use of a Systematic Review of Evidence</th>
                    </tr>
                    <tr>
                        <td headers="section">
                                            <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-5.png" alt="Excellent"/></span>

                        </td>
                        <td class="leftpadme" headers="188">Search Strategy</td>
                    </tr>
                    <tr>
                        <td headers="section">
                                            <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-4.png" alt="Very Good"/></span>

                        </td>
                        <td class="leftpadme" headers="189">Study Selection</td>
                    </tr>
                    <tr>
                        <td headers="section">
                                            <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-4.png" alt="Very Good"/></span>

                        </td>
                        <td class="leftpadme" headers="190">Synthesis of Evidence</td>
                    </tr>
                    <tr>
                        <td class="topborderme" id="blank"></td>
                        <th class="greenboldme topborderme" id="191" headers="standard">Evidence Foundations for and Rating Strength of Recommendations</th>
                    </tr>
                    <tr>
                        <td headers="section">
                                            <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-1.png" alt="Poor"/></span>

                        </td>
                        <td class="leftpadme" headers="191">Grading the Quality or Strength of Evidence</td>
                    </tr>
                    <tr>
                        <td headers="section">
                                            <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-5.png" alt="Excellent"/></span>

                        </td>
                        <td class="leftpadme" headers="192">Benefits and Harms of Recommendations</td>
                    </tr>
                    <tr>
                        <td headers="section">
                                            <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-5.png" alt="Excellent"/></span>

                        </td>
                        <td class="leftpadme" headers="193">Evidence Summary Supporting Recommendations</td>
                    </tr>
                    <tr>
                        <td headers="section">
                                            <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-4.png" alt="Very Good"/></span>

                        </td>
                        <td class="leftpadme" headers="194">Rating the Strength of Recommendations</td>
                    </tr>
                <tr>
                    <td class="topborderme" headers="section">                <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-5.png" alt="Excellent"/></span>
</td>
                    <td class="greenboldme topborderme" headers="standard">Specific and Unambiguous Articulation of Recommendations</td>
                </tr>
                <tr>
                    <td class="topborderme" headers="section">                <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-1.png" alt="Poor"/></span>
</td>
                    <td class="greenboldme topborderme" headers="standard">External Review</td>
                </tr>
                <tr>
                    <td class="topborderme" headers="section">                <span class="rating"><img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/rating-3.png" alt="Good"/></span>
</td>
                    <td class="greenboldme topborderme" headers="standard">Updating</td>
                </tr>

                        </tbody>
                    </table>
            </div>
    <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180713042756/https://www.guideline.gov/summaries/downloadcontent/ngc-11203?contentType=pdf" class="pdf">.PDF 167.3 kb</a></li>
                            <li><a href="/web/20180713042756/https://www.guideline.gov/summaries/downloadcontent/ngc-11203?contentType=word" class="word">Word Document 414.1 kb</a></li>
                            <li><a href="/web/20180713042756/https://www.guideline.gov/summaries/downloadcontent/ngc-11203?contentType=xml" class="xml">.XML 158.1 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180713042756/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/51005/acr-appropriateness-criteria--cranial-neuropathy" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180713042756/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/51005/acr-appropriateness-criteria--cranial-neuropathy" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180713042756/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/51005/acr-appropriateness-criteria--cranial-neuropathy&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180713042756/mailto:/?Subject=AHRQ: ACR Appropriateness Criteria&amp;amp;reg; cranial neuropathy.&amp;body=https://www.guideline.gov/summaries/summary/51005/acr-appropriateness-criteria--cranial-neuropathy" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: ACR Appropriateness Criteria&reg; cranial neuropathy. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2017 Jan 01. [cited 2018 Jul 13]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180713042756/https://www.guideline.gov/summaries/citedownload/51005?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180713042756/https://www.guideline.gov/summaries/citedownload/51005?format=enw">EndNote</a></li>
                            <li><a href="/web/20180713042756/https://www.guideline.gov/summaries/citedownload/51005?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180713042756/https://www.guideline.gov/summaries/citedownload/51005?format=txt">Medlars</a></li>
                            <li><a href="/web/20180713042756/https://www.guideline.gov/summaries/citedownload/51005?format=ris">ProCite</a></li>
                            <li><a href="/web/20180713042756/https://www.guideline.gov/summaries/citedownload/51005">RefWorks</a></li>
                            <li><a href="/web/20180713042756/https://www.guideline.gov/summaries/citedownload/51005?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="51005" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">ACR Appropriateness Criteria&reg;</span></strong></p>
<p><strong><span style="text-decoration: underline;">Clinical Condition</span>: Cranial Neuropathy</strong></p>
<p><strong><span style="text-decoration: underline;">Variant 1</span>: Anosmia and abnormalities of the sense of smell. (Olfactory nerve, CN I.)</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 1: Anosmia and abnormalities of the sense of smell. (Olfactory nerve, CN I.)">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">MRI head without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the orbit, face, and neck.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the head.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI head without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT maxillofacial with IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without and with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT maxillofacial without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT maxillofacial without and with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 2</span>: Weakness or paralysis of the mastication muscles. Sensory abnormalities of the head and neck. Trigeminal neuralgia. (Trigeminal nerve, CN V.)</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 2: Weakness or paralysis of the mastication muscles. Sensory abnormalities of the head and neck. Trigeminal neuralgia. (Trigeminal nerve, CN V.)">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">MRI head without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the orbit, face, and neck.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the head.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI head without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRA head without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CTA head with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT maxillofacial with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT maxillofacial without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without and with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">Contrast-enhanced imaging is preferred.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT maxillofacial without and with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without and with IV contrast</td>
            <td class="Center" valign="top">3</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">US neck</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 3</span>: Weakness or paralysis of facial expression. Hemifacial spasm. Bell palsy. (Facial nerve, CN VII.)</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 3:Weakness or paralysis of facial expression. Hemifacial spasm. Bell palsy. (Facial nerve, CN VII.)">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">MRI orbit face neck without and with IV contrast</td>
            <td class="Center" valign="top">9</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the head.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI head without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the orbit, face, and neck.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI head without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT head with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without and with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without IV contrast</td>
            <td class="Center" valign="top">3</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without and with IV contrast</td>
            <td class="Center" valign="top">3</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">US neck</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field. </p>
<p><strong><span style="text-decoration: underline;">Variant 4</span>: Palate weakness. Oropharyngeal pain. (Glossopharyngeal nerve, CN IX.)</strong> </p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 4: Palate weakness. Oropharyngeal pain. (Glossopharyngeal nerve, CN IX.)">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">MRI head without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the orbit, face, and neck.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the head.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI head without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT neck with IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">Contrast-enhanced imaging is preferred.</td>
            <td class="Center" valign="top"><img alt="radioactive" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">Contrast-enhanced imaging is preferred.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without and with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without and with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">US neck</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 5</span>: Vocal cord paralysis. (Vagal nerve, CN X.)</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 5: Vocal cord paralysis. (Vagal nerve, CN X.)">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">MRI orbit face neck without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the head. CT of the neck is an alternative examination and in some instances can be complementary.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT neck with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">MRI of the orbit, face, and neck can be an alternative examination and in some instances can be complementary.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">MRI head without and with IV contrast</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the orbit, face, and neck. CT of the neck can be useful to assess the extracranial course of CN X.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI head without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT chest with IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">MRI chest without and with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT head with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">Contrast-enhanced imaging is preferred.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT chest without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">MRI chest without IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT head without IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without and with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without and with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">X-ray chest</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">This procedure is not a first-line examination.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">US neck</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT chest without and with IV contrast</td>
            <td class="Center" valign="top">3</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 6</span>: Weakness or paralysis of the sternocleidomastoid and trapezius muscles. (Accessory nerve, CN XI.)</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 6: Weakness or paralysis of the sternocleidomastoid and trapezius muscles. (Accessory nerves, CN XI.)">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">MRI head without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the orbit, face, and neck.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the head. CT neck imaging can be complementary.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without IV contrast</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">Contrast-enhanced imaging is preferred.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT neck with IV contrast</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">MRI of the orbit, face, and neck can be an alternative examination and in some instances can be complementary.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">MRI head without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT head with IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without and with IV contrast </td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without and with IV contrast </td>
            <td class="Center" valign="top">5</td>
            <td valign="top">The panel did not agree on a recommendation.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">3</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">US neck</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 7</span>: Weakness or paralysis of the tongue. (Hypoglossal nerve, CN XII.)</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 7: Weakness or paralysis of the tongue. (Hypoglossal nerve, CN XII.)">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">MRI head without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the orbit, face, and neck.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without and with IV contrast</td>
            <td class="Center" valign="top">8</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the head.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT neck with IV contrast</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">MRI of the orbit, face, and neck is preferred, but in some instances CT neck can be complementary.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">MRI head without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT head with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without and with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without and with IV contrast</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">US neck</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Variant 8</span>: Perineural spread of tumor. (Most commonly trigeminal nerve [CN V], facial nerve [CN VII].)</strong></p>
<table border="1" cellspacing="1" cellpadding="5" summary="Table: Variant 8: Perineural spread of tumor. (Most commonly trigeminal nerve [CN V], facial nerve [CN VII].)">
    <thead>
        <tr>
            <th width="30%" class="Center" valign="top" scope="col">Radiologic Procedure</th>
            <th width="15%" class="Center" valign="top" scope="col">Rating</th>
            <th width="40%" class="Center" valign="top" scope="col">Comments</th>
            <th width="25%" class="Center" valign="top" scope="col">RRL*</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td valign="top">MRI head without and with IV contrast</td>
            <td class="Center" valign="top">9</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the orbit, face, and neck.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without and with IV contrast</td>
            <td class="Center" valign="top">9</td>
            <td valign="top">This procedure is performed in conjunction with MRI of the head.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">MRI orbit face neck without IV contrast</td>
            <td class="Center" valign="top">7</td>
            <td valign="top">Addition of contrast-enhanced imaging is preferred.</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT neck with IV contrast</td>
            <td class="Center" valign="top">6</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">MRI head without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
        <tr>
            <td valign="top">CT head with IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without IV contrast</td>
            <td class="Center" valign="top">5</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT head without and with IV contrast </td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">CT neck without and with IV contrast </td>
            <td class="Center" valign="top">4</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">FDG-PET/CT whole body</td>
            <td class="Center" valign="top">4</td>
            <td valign="top">This procedure is not a first-line examination.</td>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
        </tr>
        <tr>
            <td valign="top">US neck</td>
            <td class="Center" valign="top">2</td>
            <td valign="top">&nbsp;</td>
            <td class="Center" valign="top">O</td>
        </tr>
    </tbody>
    <tfoot>
    <tr>
        <th class="Center" valign="top" colspan="3"><span style="text-decoration: underline;">Rating Scale</span>: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate</th>
        <th class="Center" valign="top">*Relative Radiation Level</th>
    </tr>
    </tfoot>
</table>
<p>Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Summary of Literature Review</span></strong></p>
<p><strong>Introduction/Background</strong></p>
<p>The cranial nerves arise from nuclei within the brain and brainstem and supply sensory and motor innervation to the head and neck region, whereas the spinal nerves arise from the spinal cord and supply the rest of the body. As a group, the cranial nerves have both sensory and motor components similar to those of the spinal nerves. Individually the cranial nerves may be purely sensory or purely motor or a mixture of both sensory and motor. Functions of the cranial nerves may be divided into 3 sensory and 3 motor categories. The sensory group includes visceral sensory, which supplies sensory input from the internal organs; general sensory, which supplies tactile, pain, temperature and other sensations; and special sensory, which includes the special senses of smell, vision, taste, hearing, and balance. Of the 3 motor functions, somatic motor innervates muscles that develop from the body somites; branchial motor innervates muscles derived from the branchial arches; and visceral motor innervates the viscera, glands, and smooth muscle.</p>
<p>Cranial nerves emerge in an orderly fashion from the rostral portion of the embryologically developing neural tube, which will subsequently mature to form the brain and brain stem. Anatomically, the 12 pairs of cranial nerves are designated by numbers and are organized most rostral to most caudal in descending order. The cranial nerves (CN) include the olfactory (CN I), optic (CN II), oculomotor (CN III), trochlear (CN IV), trigeminal (CN V), abducens (CN VI), facial (CN VII), vestibulocochlear (CN VIII), glossopharyngeal (CN IX), vagus (CN X), spinal accessory (CN XI), and hypoglossal (CN XII) nerves. The olfactory (CN I) and optic (CN II) nerves are actually tracts formed from the telencephalon and diencephalon, respectively, and are not considered true nerves. The optic (CN II), oculomotor (CN III), trochlear (CN IV), and abducens (CN VI) nerves are considered functionally to be part of the visual and extraocular motor system and have been discussed in the National Guideline Clearinghouse (NGC) summary of the <a href="/web/20180713042756/https://www.guideline.gov/summaries/summary/37934" title="Guideline #9239" target="_blank">ACR Appropriateness Criteria&reg; orbits, vision and visual loss</a>. Also, the vestibulocochlear nerve (CN VIII) has been reviewed in the NGC summary of the <a href="/web/20180713042756/https://www.guideline.gov/summaries/summary/47674" title="Guideliine #10159" target="_blank">ACR Appropriateness Criteria&reg; hearing loss and/or vertigo</a>. Therefore, this discussion will focus on cranial nerves CN I, CN V, CN VII, CN IX, CN X, CN XI, and CN XII.</p>
<p>In approaching cranial neuropathy, several concepts should be emphasized:</p>
<ol style="list-style-type: decimal;">
    <li>Because of the complex anatomic structures within the brain and brainstem and because the cranial nerves may take long, circuitous routes to their destinations, a detailed knowledge of cranial nerve anatomy is essential for proper clinical localization of potential lesions and for appropriate application of specific imaging protocols. </li>
    <li>Because some individual nerve fibers, such as the autonomic nerves, may travel with several different cranial nerves from their nuclei of origin to their ultimate destinations, loss of a specific function may indicate involvement of potentially more than 1 cranial nerve. </li>
    <li>Because of the close proximity of many cranial nerve nuclei and of many exiting sites of the nerves themselves, some mass lesions may involve multiple cranial nerves. </li>
</ol>
<p><strong>Special Imaging Considerations</strong></p>
<p>In the evaluation of cranial neuropathy complete evaluation of the nerves from their brainstem nuclei to their "end organs" must be performed. The pathology can be located in the nucleus, cisternae, and skull base segments of the cranial nerves. For cranial nerve VII, the lesion can also be located in the parotid. For cranial nerves IX, X, XI, and XII, the lesion can also be located in the neck. Evaluation of the upper chest is necessary for complete evaluation of the CN X (recurrent laryngeal) course. This can be accomplished by extending the neck scan into the mid thorax (aortic pulmonary window) or dedicated chest computed tomography (CT). Patients presenting with otalgia may require evaluation of CN V, VII, IX, and X and upper cervical nerves C2 and C3 since any of these nerves may be the source for the otalgia. The use of intravenous contrast is imperative for the evaluation of cranial neuropathy with magnetic resonance imaging (MRI). Neck CT also requires the utilization of contrast when evaluating pathology affecting the neck. Dual-phase CT before and after administration of contrast is rarely necessary. This should be avoided because of the extra radiation exposure and minimal added benefits.</p>
<p>The primary plane of study for head and neck evaluation of cranial neuropathy is usually the axial plane. Additional orthogonal planes are required depending upon the course of the various nerves. Coronal and sagittal reconstructions are typically performed on CT. In order to obtain high-resolution orthogonal reconstructions, the axial plane is acquired with thin sections, typically &lt;1 mm. On MRI, orthogonal reconstructions are typically performed on the postcontrast T1-weighted images; however, they can also be obtained on T2-weighted images. Thin-section MRI images are required to evaluate the cisternal segment and should be performed.</p>
<p>High-field-strength magnets (1.5T&ndash;3.0T) are preferred to low-field-strength units because of achievable signal to noise ratios, gradient strength, and spatial resolution. A phased-array head coil suffices for most examinations; specialized surface coils may supplement examinations of peripherally located nerves.</p>
<p>Fundamental techniques include T1-weighted, T2-weighted, and enhanced T1-weighted imaging sequences. The unenhanced T1-weighted sequence remains an excellent baseline technique for anatomical evaluation because of the natural contrast provided by neck and skull base fat. Specialized versions of sequences may be available on scanners depending on manufacturer options. For example, various three-dimensional (3-D) and heavily T2-weighted sequences&mdash;such as constructive interference in steady state, 3-D&ndash;balanced fast field echo, 3-D&ndash;driven equilibrium radio frequency reset pulse, 3-D fast spin echo, fast imaging using steady-state acquisition, and 3-D fast spin-echo extended echo-train acquisition&mdash;may provide excellent spatial resolution of the cisternal segments of some of the cranial nerves, but they must be used judiciously because of potentially misleading artifacts. Enhanced fat-suppression T1-weighted techniques may emphasize abnormally enhancing lesions and nerves but may potentially mask subtle pathology if the suppression is nonuniform. Additional sequences, such as diffusion-weighted imaging, may be added to evaluate specific pathologies, such as infarctions, or specific lesions, such as epidermoids, that may affect cranial nerve function. Slice thickness should be calculated for optimal spatial resolution without introducing partial-volume effect. Because cranial nerve examinations tend to be lengthy, strategies such as parallel imaging may improve patient compliance and image quality.</p>
<p><strong>Discussion of Procedures by Variant</strong></p>
<p><em>Variant 1: Anosmia and Abnormalities of the Sense of Smell. (Olfactory Nerve, CN I)</em></p>
<p>Abnormalities of the special sense of smell are mediated by the olfactory nerve (CN I) and can be grouped into clinical categories. Quantitative disturbances imply diminished or enhanced sense of smell (anosmia, hyposmia, or hyperosmia). Qualitative disturbances involve distortions of the sense of smell (dysosmia). Discrimination disturbances involve an inability to differentiate among various smells. Hallucinations or delusions in the sense of smell may also occur. The latter may be caused by temporal lobe dysfunction (see the NGC summary of the <a href="/web/20180713042756/https://www.guideline.gov/summaries/summary/48287" title="Guideline #10452" target="_blank">ACR Appropriateness Criteria&reg; seizures and epilepsy</a>) or by degenerative or psychiatric disease. Taste, mediated by the facial (CN VII) and glossopharyngeal (CN IX) nerves, may also be affected by pathology involving the olfactory nerve (CN I).</p>
<p>Most patients with olfactory complaints do not require imaging. Chronic tobacco use, upper respiratory infections, and inflammatory conditions most commonly affect the sense of smell. More serious conditions affecting the olfactory nerve include trauma (the olfactory nerve is the nerve most commonly disrupted by trauma); cribriform plate tumors such as invasive squamous cell carcinomas of the paranasal sinuses, meningiomas, and esthesioneuroblastomas; inflammatory lesions such as sarcoidosis and granulomatosis with polyangiitis (formerly known as Wegener granulomatosis); and congenital conditions such as cephaloceles and Kallmann syndrome. Recent investigations have focused on olfactory bulb volume as an indicator of olfactory dysfunction and even a marker for such disorders as early Parkinson disease and depression.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging and Computed Tomography</span></p>
<p>MRI is the mainstay for examining the olfactory apparatus, although CT remains useful when evaluating fractures, paranasal sinus inflammatory disease, and bony anatomy. Imaging protocols should cover the major anatomic divisions of the olfactory nerve and pathway, including the olfactory epithelium, which is located in the upper nasal cavity; the olfactory neurons and bulbs, located in the cribriform plate and inferior frontal lobes; and the olfactory pathways, which travel in portions of the temporal and frontal lobes.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT and Other Imaging Modalities</span> </p>
<p>Efforts using functional MRI, single-photon emission CT, and fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in studying olfactory dysfunction remain largely investigative and are not generally used in routine evaluations.</p>
<p><em>Variant 2: Weakness or Paralysis of the Mastication Muscles. Sensory Abnormalities of the Head and Neck. Trigeminal Neuralgia. (Trigeminal Nerve, CN V)</em></p>
<p>The trigeminal nerve (CN V) provides general sensation to large portions of the head and neck and branchial motor innervation to the muscles of mastication. It is the largest cranial nerve and is divided into 3 main divisions, known as the ophthalmic (V1), maxillary (V2), and mandibular (V3) branches. Symptoms largely depend on the involved segment and division. Abnormalities of the nerve may manifest as sensory disturbances, such as trigeminal neuralgia (<em>tic douloureux</em>), facial numbness, or motor abnormalities such as weakness when chewing food.</p>
<p>The trigeminal nerve (CN V) is the nerve of the first branchial arch and may be involved in congenital conditions such as Goldenhar-Gorlin syndrome. Intra-axial and extra-axial processes may affect the brainstem trigeminal nuclei and nerve root entry and exit zones. Conditions localized to the brainstem portion of the trigeminal nerve (CN V) include vascular lesions (such as compressing vascular loops, aneurysms, vertebrobasilar dolichoectasia, and infarctions), inflammatory and infectious conditions (such as meningitis, encephalitis, sarcoidosis, and multiple sclerosis), and tumors (such as gliomas, lymphomas, metastases, and meningiomas). The cisternal portion of the nerve may be especially vulnerable to compression from adjacent vascular loops, causing trigeminal neuralgia. Tumors, vascular lesions, and inflammatory processes may also affect the branches of the nerve as they traverse the Meckel cave, the pterygopalatine fossa, the orbit, the skull base, and the masticator space.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging and Computed Tomography</span></p>
<p>MRI is the preferred modality for investigating the trigeminal nerve (CN V). CT is very useful for evaluating the skull base and neural foramina. Three-dimensional and heavily T2-weighted magnetic resonance (MR) sequences and MR and CT angiography are helpful noninvasive methods for reviewing the anatomy of potentially compressing vascular loops. Patients may benefit from MRI studies performed in a high-strength magnet (3T), given the higher anatomic resolution. With the growing popularity of radiosurgery, such as gamma knife procedures, and radiofrequency thermocoagulation in the treatment of trigeminal neuralgia, both CT and MRI have become indispensable planning and follow-up tools, although imaging may not reliably predict outcome. Because of the complex branching patterns of the nerve, multiple imaging planes are essential.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>US is not routinely used in the initial evaluation of the trigeminal nerve.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>PET is not routinely used in the initial evaluation of the trigeminal nerve.</p>
<p><span style="text-decoration: underline;">Advanced Imaging Modalities</span></p>
<p>Advanced imaging applications, such as fractional anisotropy derived from diffusion tensor imaging and virtual endoscopy, are promising future directions in investigating trigeminal neuralgia.</p>
<p><em>Variant 3: Weakness or Paralysis of Facial Expression. Hemifacial Spasm. Bell Palsy. (Facial Nerve, CN VII)</em></p>
<p>The facial nerve (CN VII) is one of the most complex cranial nerves and contains branchial motor (innervation to the muscles of facial expression), visceral motor (parasympathetic innervation to most of the glands of the head), general sensory (surface innervations to a small portion of the external ear and tympanic membrane), and special sensory (taste to the anterior two-thirds of the tongue) functions. It is the one of the most commonly paralyzed nerves in the body, and most of the clinical attention it receives focuses on its role in facial expression. Tinnitus, conductive and sensorineural hearing loss, and hemifacial spasm may also signal a lesion involving the facial nerve.</p>
<p>The intracranial course of the facial nerve includes pontine, cisternal, and intratemporal segments. Within the pons, the facial nuclei can be affected by intra-axial conditions such as infarction, vascular malformations, tumors, and multiple sclerosis. As the nerve exits the brainstem and courses through the temporal bone, it may be affected by facial and vestibular schwannomas, meningiomas, vascular lesions, inflammation, cholesteatomas, paragangliomas, trauma, and intrinsic bone tumors. The extracranial segment of the facial nerve courses through the parotid gland and may be affected by parotid tumors and inflammation and conditions of the neighboring anatomic spaces and skull base such as carcinomas, sarcomas, trauma, and inflammatory disease.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging</span></p>
<p>MRI is the mainstay of evaluating both intracranial and extracranial portions of the facial nerve. Facial paralysis in the form of Bell palsy is one of the most common syndromes confronting the otolaryngologist. In general, Bell palsy patients need not be imaged unless the symptoms are atypical or persist for &gt;2 months. When imaging is considered, MRI is the method of choice. Enhancement may be seen in the canalicular, labyrinthine, geniculate, tympanic, and mastoid portions of the nerve in neuritis, although geniculate, tympanic, and mastoid portions may enhance normally. MRI may also be useful in establishing prognosis; however, there is 1 current study with a small cohort of patients that shows no association between the degree of enhancement and the clinical severity of facial nerve palsy in the early stage, stating that predicting the prognosis is difficult.</p>
<p><span style="text-decoration: underline;">Computed Tomography</span></p>
<p>CT provides useful information regarding temporal bone fractures and trauma, presurgical osseous anatomy, nerve involvement with inflammatory middle ear disease, foraminal expansion, patterns of bone erosion, and intrinsic bone tumor matrices. In patients with risk of contrast allergy and contrast-induced nephropathy, a noncontrast CT may be sufficient if patients cannot undergo MRI. A dedicated temporal bone CT with thin sections should be obtained instead of a head CT to evaluate the course of CN VII.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>US is not routinely used in the initial evaluation of the facial nerve.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>PET is not routinely used in the initial evaluation of the facial nerve.</p>
<p><em>Variant 4: Palate Weakness. Oropharyngeal Pain. (Glossopharyngeal Nerve, CN IX)</em></p>
<p>The glossopharyngeal nerve (CN IX) arises in the medulla and is responsible for branchial motor innervation to the stylopharyngeus muscle, which elevates the palate, and visceral motor parasympathetic innervation to the parotid gland. Visceral sensory innervation to the carotid sinus plays a role in regulating circulation and general and special sensory functions that supply sensation and taste to the posterior tongue. The nerve exits the jugular foramen in close proximity to the vagus (CN X) and the spinal accessory (CN XI) nerves. Therefore, isolated syndromes involving the glossopharyngeal nerve are rare. Intra-axial lesions include gliomas, lymphomas, metastases, vascular malformations, infarctions, and inflammatory abnormalities. Multiple sclerosis may also affect the medulla adjacent to the cranial nerve nuclei. Leptomeningeal metastases, granulomatous disease, and even tortuous or aneurysmal dilatation of vessels may affect the nerve as it enters the cistern. Lesions in the region of the posterior skull base and jugular foramen, such as metastases, schwannomas, paragangliomas, and meningiomas, usually also involve the other lower cranial nerves. Tonsillar pain syndromes, palate weakness, and loss of gag reflex accompanied by loss of taste and sensation in the posterior pharynx may signal a glossopharyngeal nerve lesion.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging and Computed Tomography</span></p>
<p>As with the other cranial nerves, MRI of CN IX is the preferred modality for investigating possible lesions such as masses or vascular compression, with CT providing information on the bony integrity of the foramina. Imaging protocols should focus on the posterior skull base and upper neck.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>US is not routinely used in the initial evaluation of the glossopharyngeal nerve.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>PET is not routinely used in the initial evaluation of the glossopharyngeal nerve.</p>
<p><em>Variant 5: Vocal Cord Paralysis. (Vagal Nerve, CN X)</em></p>
<p>The vagus nerve (CN X) supplies visceral sensation to the pharynx, larynx, and viscera and general sensation to the ear. Branchial motor branches innervate muscles of the pharynx and larynx, whereas visceral motor branches play a predominant role in parasympathetic supply to the thorax and abdomen. The vagus nerve boasts the longest course in the body of any cranial nerve and is therefore vulnerable to a wide range of pathologies occurring throughout its trajectory from the posterior fossa and skull base to the neck, thorax, and abdomen. Intracranial processes such as meningiomas, schwannomas, metastases, granulomatous disease, ischemia, vascular conditions, and infection may affect the vagal nuclei and the nerve as it exits the medulla. Paragangliomas, schwannomas, and metastases involving the skull base may affect the nerve and the neighboring glossopharyngeal nerve (CN IX) by infiltration of fibers or by compression. Within the neck, trauma may also affect the vagus nerve, in addition to masses, vascular lesions, thyroid conditions, infection, or inflammation. Viral neuropathy may be one of the most common causes of idiopathic vagal palsies.</p>
<p>One of the most troubling symptoms of vagus dysfunction is vocal cord paralysis. Because lesions anywhere in the long course of the nerve may potentially cause paralysis, the imaging protocol must visualize the full extent of the nerve from the skull base to the mid chest.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging, Computed Tomography, and Radiography</span></p>
<p>With its rapid scanning time and availability, CT provides an excellent means of examining the lower course of the nerve. Moreover, thoracic causes of paralysis, such as lung cancer, tuberculosis, and thoracic aortic aneurysm, are common. Although chest radiographs may detect many of these causes, chest CT is more sensitive, especially for lesions concealed in the aortopulmonary window. This can also be accomplished by extending the neck CT scanning to the mid thorax. For imaging of the upper course of the nerve including the skull base, MRI is preferred. For the mid neck and larynx, CT and MRI complement one another. For example, CT may differentiate traumatic arytenoid dislocation from neurogenic paralysis. Rapid multislice CT scanning, including functional 3-D applications, also allows the patient to perform phonation and breathing maneuvers during imaging to augment diagnosis. In patients with risk of contrast allergy and contrast-induced nephropathy, a noncontrast CT may be sufficient if patients cannot undergo MRI.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>US may also have a role in imaging of the neck. It may be useful for assessing lesions such as tumors or lymphadenopathy that have caused CN X neuropathy. It can be utilized in cases of neck lesions as a problem-solving technique. It can also be used as a technique to guide biopsies of lesions in the neck.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>PET imaging used for evaluating head and neck malignancy may yield false-positive findings in the larynx for patients with vocal cord paralysis or unrecognized physiological asymmetry. It may be useful as a problem-solving technique following initial cross-sectional imaging in patients with a known primary malignancy. PET/CT may also be superior to cross-sectional imaging for both localization and determination of response to therapy.</p>
<p><span style="text-decoration: underline;">Radiographs</span></p>
<p>Chest radiographs can be utilized as a screening tool if chest CT or chest MRI is unavailable or contraindicated. It can reveal lesions in the lung apex or mediastinum that may cause CN X deficits.</p>
<p><em>Variant 6: Weakness or Paralysis of the Sternocleidomastoid and Trapezius Muscles. (Accessory Nerve, CN XI)</em></p>
<p>The spinal accessory nerve (CN XI) supplies the sternocleidomastoid muscle and the upper portion of the trapezius muscle as its sole branchial motor function. Palsy is clinically manifested by weakness and atrophy of these muscles and may be accompanied by evidence of involvement of the glossopharyngeal (CN IX) and vagus (CN X) nerves in combined syndromes. Loss of volume and fatty infiltration of the sternocleidomastoid and trapezius muscles may be noted on imaging.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging and Computed Tomography</span></p>
<p>CT and MRI are complementary in diagnosing conditions such as posterior fossa and skull base infarctions, vascular lesions, Chiari malformations, paragangliomas, schwannomas, meningiomas, and metastases or in recognizing nerve involvement from prior neck surgeries. In patients with risk of contrast allergy and contrast-induced nephropathy, a noncontrast CT may be sufficient if patients cannot undergo MRI. Protocol with thin-section MRI should be performed to evaluate the cranial nerves.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>US is not routinely used in the initial evaluation of the accessory nerve.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>PET is not routinely used in the initial evaluation of the accessory nerve.</p>
<p><em>Variant 7: Weakness or Paralysis of the Tongue. (Hypoglossal Nerve, CN XII)</em></p>
<p>The hypoglossal nerve (CN XII) supplies somatic motor innervation to the intrinsic and extrinsic muscles of the tongue, except the palatoglossus muscle. Palsy of this nerve is recognized by dysarthria and deviation of the tongue to the affected side on protrusion. Atrophy and fatty infiltration of the tongue may be noted on imaging. Lesions of the posterior fossa, skull base, upper neck, and floor of the mouth may affect the hypoglossal nerve. They include infarctions, meningiomas, schwannomas, paragangliomas, carcinomas, metastases, subarachnoid hemorrhage, Chiari malformations, basilar invagination, and fractures.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging and Computed Tomography</span></p>
<p>As with the other lower cranial nerves, MRI is the preferred modality for CN XII, and CT provides complementary information on the integrity of the bony structures and foramina. Evaluation of the entire course of the nerve is required, which includes evaluation of the nucleus in the brainstem medulla and the nerve in the cisternal segment and high carotid space. This is preferably obtained with a neck MRI that covers the entire nerve pathway. In patients with risk of contrast allergy and contrast-induced nephropathy, a noncontrast CT may be sufficient if patients cannot undergo MRI.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>US is not routinely used in the initial evaluation of the hypoglossal nerve.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>PET is not routinely used in the initial evaluation of the hypoglossal nerve.</p>
<p><em>Variant 8: Perineural Spread of Tumor. (Most Commonly Trigeminal Nerve [CN V], Facial Nerve [CN VII])</em></p>
<p>Because of the complex anatomy of the head and neck and the close proximity of several cranial nerves, many clinical presentations of cranial neuropathy involve multiple nerves. As in syndromes of combined neuropathy of the upper cranial nerves, such as those related to vision and the extraocular muscles (which are covered in other Appropriateness Criteria), syndromes involving the lower cranial nerves are also grouped primarily by the proximity of the involved cranial nerves. For example, Gradenigo syndrome involves CNs V and VI as they travel in the vicinity of the petrous apex, whereas Vernet syndrome involves CNs IX, X, and XI as they travel within the jugular foramen. Collet-Sicard syndrome involves CNs IX, X, XI, and XII related to lesions just below the skull base or large lesions affecting both the jugular foramen and the hypoglossal canal. Imaging protocols should be tailored to evaluate the suspected region of anatomy when the syndrome is identified by the clinician.</p>
<p>A difficult problem for the surgeon is the perineural spread of head and neck malignancy. The trigeminal (CN V) and facial (CN VII) are the most common nerves involved; however, any cranial nerve traveling in the vicinity of a malignancy may become involved. Perineural spread of tumor along the facial nerve may evade even the most meticulous imaging. Subtle clues such as nerve enhancement, nerve enlargement, foraminal expansion, or muscle volume loss may indicate cranial nerve involvement with tumor. For example, asymmetry of facial musculature may be useful in detecting perineural tumor spread along the facial nerve or predicting return of function after nerve grafting.</p>
<p><span style="text-decoration: underline;">Magnetic Resonance Imaging and Computed Tomography</span></p>
<p>MRI has emerged as the preferred imaging method for evaluating the perineural spread of tumor, although CT may be very useful for visualizing the neural foramina. In patients with risk of contrast allergy and contrast-induced nephropathy, a noncontrast CT may be sufficient if patients cannot undergo MRI. Protocol with thin-section MRI should be performed to evaluate the cranial nerves.</p>
<p><span style="text-decoration: underline;">FDG-PET/CT</span></p>
<p>PET imaging may also be helpful. It may be useful as a problem-solving technique following initial cross-sectional imaging in patients with a known primary malignancy. PET/CT may also be superior to cross-sectional imaging for both localization and determination of response to therapy.</p>
<p><span style="text-decoration: underline;">Ultrasound</span></p>
<p>US is not routinely used in the initial evaluation of the perineural spread of tumor.</p>
<p><strong>Summary of Recommendations</strong></p>
<ul style="list-style-type: disc;">
    <li>Pathology affecting the olfactory nerve is best evaluated with contrast-enhanced MRI. The protocol should be tailored to the anterior cranial fossa. CT may be useful in the evaluation of sinus inflammatory disease and trauma. </li>
    <li>Contrast-enhanced MRI is the primary technique to evaluate trigeminal neuralgia. MR angiography can be used to evaluate vascular compression. </li>
    <li>Facial nerve neuropathy is best evaluated with a dedicated contrast-enhanced MRI of the orbit, face, and neck, tailored to the temporal bone and parotid area. </li>
    <li>In the evaluation of cranial nerve IX symptoms, a focused contrast-enhanced MRI tailored to the posterior fossa is the study of choice. </li>
    <li>Cranial nerve X paralysis is well evaluated with either contrast-enhanced MRI or contrast-enhanced neck CT. Pathology in the posterior fossa will be better demonstrated with MRI. The complete evaluation of the nerve requires imaging the upper chest to the level of the anteroposterior window. </li>
    <li>In the evaluation of cranial nerve XI symptoms, a focused contrast-enhanced MRI tailored to the posterior fossa is the study of choice. Contrast-enhanced CT of the neck is complementary to the skull base imaging. </li>
    <li>Evaluation of lesions affecting cranial nerve XII is best done with a contrast-enhanced MRI tailored to the posterior fossa. The evaluation of the neck can also be done with contrast-enhanced neck CT. </li>
    <li>Perineural tumor spread most commonly affects CNs V and VII. Evaluation is best done with contrast-enhanced MRI tailored to the skull base. </li>
</ul>
<p><strong>Abbreviations</strong></p>
<ul style="list-style-type: disc;">
    <li>CN, cranial nerve </li>
    <li>CT, computed tomography </li>
    <li>CTA, computed tomography angiography </li>
    <li>FDG-PET, fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography </li>
    <li>IV, intravenous </li>
    <li>MRA, magnetic resonance angiography </li>
    <li>MRI, magnetic resonance imaging </li>
    <li>US, ultrasound </li>
</ul>
<p><strong>Relative Radiation Level Designations</strong></p>
<table width="50%" border="1" cellspacing="3" cellpadding="5" summary="Table: Relative Radiation Level Definitions">
    <thead>
        <tr>
            <th class="Center" valign="top">Relative Radiation Level*</th>
            <th class="Center" valign="top">Adult Effective Dose Estimate Range</th>
            <th class="Center" valign="top">Pediatric Effective Dose Estimate Range</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td class="Center" valign="top">O</td>
            <td class="Center" valign="top">0 mSv</td>
            <td class="Center" valign="top">0 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td class="Center" valign="top">&lt;0.1 mSv</td>
            <td class="Center" valign="top">&lt;0.03 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td class="Center" valign="top">0.1-1 mSv</td>
            <td class="Center" valign="top">0.03-0.3 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td class="Center" valign="top">1-10 mSv</td>
            <td class="Center" valign="top">0.3-3 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td class="Center" valign="top">10-30 mSv</td>
            <td class="Center" valign="top">3-10 mSv</td>
        </tr>
        <tr>
            <td class="Center" valign="top"><img alt="radioactive symbol 1" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 2" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 3" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 4" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/> <img alt="radioactive symbol 5" src="https://web.archive.org/web/20180713042756im_/http://guideline.gov/images/image_radioactive.gif "/></td>
            <td class="Center" valign="top">30-100 mSv</td>
            <td class="Center" valign="top">10-30 mSv</td>
        </tr>
        <tr>
            <td valign="top" colspan="3">*RRL assignments for some of the examinations cannot be made, because the actual patient doses in these procedures vary as a function of a number of factors (e.g., region of the body exposed to ionizing radiation, the imaging guidance that is used). The RRLs for these examinations are designated as "Varies."</td>
        </tr>
    </tbody>
</table></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>Algorithms were not developed from criteria guidelines.</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Cranial neuropathy</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Diagnosis</p>
                    <p>Evaluation</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Family Practice</p>
                    <p>Internal Medicine</p>
                    <p>Neurological Surgery</p>
                    <p>Neurology</p>
                    <p>Oncology</p>
                    <p>Otolaryngology</p>
                    <p>Radiology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Health Care Providers</p>
                    <p>Health Plans</p>
                    <p>Hospitals</p>
                    <p>Managed Care Organizations</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                    <p>Students</p>
                    <p>Utilization Management</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To evaluate the appropriateness of imaging procedures for patients with cranial neuropathy</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Patients with cranial neuropathy</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><ol style="list-style-type: decimal;">
    <li>Magnetic resonance imaging (MRI)
    <ul style="list-style-type: disc;">
        <li>Head without and with intravenous (IV) contrast </li>
        <li>Head without IV contrast </li>
        <li>Orbit face neck without and with IV contrast </li>
        <li>Orbit face neck without IV contrast </li>
        <li>Chest without and with IV contrast </li>
        <li>Chest without IV contrast </li>
    </ul>
    </li>
    <li>Magnetic resonance angiography, head without IV contrast </li>
    <li>Computed tomography (CT)
    <ul style="list-style-type: disc;">
        <li>Maxillofacial with IV contrast </li>
        <li>Maxillofacial without IV contrast </li>
        <li>Maxillofacial without and with IV contrast </li>
        <li>Head with IV contrast </li>
        <li>Head without IV contrast </li>
        <li>Head without and with IV contrast </li>
        <li>Neck with IV contrast </li>
        <li>Neck without IV contrast </li>
        <li>Neck without and with IV contrast </li>
        <li>Chest with IV contrast </li>
        <li>Chest without IV contrast </li>
        <li>Chest without and with IV contrast </li>
    </ul>
    </li>
    <li>Computed tomography angiography, head with IV contrast </li>
    <li>Fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)/CT, whole body </li>
    <li>Ultrasound (US), neck </li>
    <li>X-ray, chest </li>
</ol></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Utility of imaging procedures in the diagnosis and evaluation of cranial neuropathies </li>
    <li>Sensitivity, specificity, and accuracy of imaging procedures in the diagnosis and evaluation of cranial neuropathies </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Literature Search Summary</span></strong></p>
<p>Of the 130 citations in the original bibliography, 117 were retained in the final document.</p>
<p>A literature search was conducted in April 2015 and March 2017 to identify additional evidence published since the <em>ACR Appropriateness Criteria&reg; Cranial Neuropathy</em> topic was finalized. Using the search strategies described in the literature search companion (see the "Availability of Companion Documents" field), 559 articles were found. Thirteen articles were added to the bibliography. The remaining articles were not used due to either poor study design, the articles were not relevant or generalizable to the topic, or the results were unclear or biased.</p>
<p>The author added 2 citations from bibliographies, Web sites, or books that were not found in the literature searches that were found outside of the search date ranges.</p>
<p>Four citations are supporting documents that were added by staff.</p>
<p>See also the American College of Radiology (ACR) Appropriateness Criteria&reg; literature search process document (see the "Availability of Companion Documents" field) for further information.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Of the 130 citations in the original bibliography, 117 were retained in the final document. The literature search conducted in April 2015 and March 2017 identified 13 articles that were added to the bibliography. The author added 2 citations from bibliographies, Web sites, or books that were not found in the literature searches that were found outside of the search date ranges. Four citations are supporting documents that were added by staff.</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Definitions of Study Quality Categories</span></strong></p>
<p>Category 1 - The study is well-designed and accounts for common biases.</p>
<p>Category 2 - The study is moderately well-designed and accounts for most common biases.</p>
<p>Category 3 - The study has important study design limitations.</p>
<p>Category 4 - The study or source is not useful as primary evidence. The article may not be a clinical study, the study design is invalid, or conclusions are based on expert consensus.</p>
<p class="Indent">The study does not meet the criteria for or is not a hypothesis-based clinical study (e.g., a book chapter or case report or case series description);</p>
<p class="Indent"><em>Or</em></p>
<p class="Indent">The study may synthesize and draw conclusions about several studies such as a literature review article or book chapter but is not primary evidence;</p>
<p class="Indent"><em>Or</em></p>
<p class="Indent">The study is an expert opinion or consensus document.</p>
<p>Category M - Meta-analysis studies are not rated for study quality using the study element method because the method is designed to evaluate individual studies only. An "M" for the study quality will indicate that the study quality has not been evaluated for the meta-analysis study.</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Systematic Review with Evidence Tables</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>The topic author assesses the literature then drafts or revises the narrative summarizing the evidence found in the literature. American College of Radiology (ACR) staff drafts an evidence table based on the analysis of the selected literature. These tables rate the study quality for each article included in the narrative.</p>
<p>The expert panel reviews the narrative, evidence table and the supporting literature for each of the topic-variant combinations and assigns an appropriateness rating for each procedure listed in the variant table(s). Each individual panel member assigns a rating based on his/her interpretation of the available evidence.</p>
<p>More information about the evidence table development process can be found in the ACR Appropriateness Criteria&reg; Evidence Table Development document (see the "Availability of Companion Documents" field).</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus (Delphi)</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Rating Appropriateness</span></strong></p>
<p>The American College of Radiology (ACR) Appropriateness Criteria (AC) methodology is based on the RAND Appropriateness Method. The appropriateness ratings for each of the procedures or treatments included in the AC topics are determined using a modified Delphi method. A series of surveys are conducted to elicit each panelist's expert interpretation of the evidence, based on the available data, regarding the appropriateness of an imaging or therapeutic procedure for a specific clinical scenario. The expert panel members review the evidence presented and assess the risks or harms of doing the procedure balanced with the benefits of performing the procedure. The direct or indirect costs of a procedure are not considered as a risk or harm when determining appropriateness. When the evidence for a specific topic and variant is uncertain or incomplete, expert opinion may supplement the available evidence or may be the sole source for assessing the appropriateness.</p>
<p>The appropriateness is represented on an ordinal scale that uses integers from 1 to 9 grouped into three categories: 1, 2, or 3 are in the category "usually not appropriate" where the harms of doing the procedure outweigh the benefits; and 7, 8, or 9 are in the category "usually appropriate" where the benefits of doing a procedure outweigh the harms or risks. The middle category, designated "may be appropriate," is represented by 4, 5, or 6 on the scale. The middle category is when the risks and benefits are equivocal or unclear, the dispersion of the individual ratings from the group median rating is too large (i.e., disagreement), the evidence is contradictory or unclear, or there are special circumstances or subpopulations which could influence the risks or benefits that are embedded in the variant.</p>
<p>The ratings assigned by each panel member are presented in a table displaying the frequency distribution of the ratings without identifying which members provided any particular rating. To determine the panel's recommendation, the rating category that contains the median group rating without disagreement is selected. This may be determined after either the first or second rating round. If there is disagreement after the first rating round, a conference call is scheduled to discuss the evidence and, if needed, clarify the variant or procedure description. If there is disagreement after the second rating round, the recommendation is "May be appropriate."</p>
<p>This modified Delphi method enables each panelist to articulate his or her individual interpretations of the evidence or expert opinion without excessive influence from fellow panelists in a simple, standardized, and economical process. For additional information on the ratings process see the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRatingRoundInfo.pdf" title="ACR Web site">Rating Round Information</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> document.</p>
<p>Additional methodology documents, including a more detailed explanation of the complete topic development process and all ACR AC topics can be found on the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acr.org%2fQuality-Safety%2fAppropriateness-Criteria" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> (see also the "Availability of Companion Documents" field).</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p>Not applicable</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>Criteria developed by the Expert Panels are reviewed by the American College of Radiology (ACR) Committee on Appropriateness Criteria.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The recommendations are based on analysis of the current medical evidence literature and the application of the RAND/UCLA appropriateness method and expert panel consensus.</p>
<p><strong><span style="text-decoration: underline;">Summary of Evidence</span></strong></p>
<p>Of the 136 references cited in the <em>ACR Appropriateness Criteria&reg; Cranial Neuropathy</em> document, 2 are categorized as therapeutic references, including 1 good-quality study. Additionally, 134 references are categorized as diagnostic references, including 3 well-designed studies, 19 good-quality studies, and 46 quality studies that may have design limitations. There are 67 references that may not be useful as primary evidence.</p>
<p>Although there are references that report on studies with design limitations, 23 well-designed or good-quality studies provide good evidence.</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>Use of appropriate imaging procedures in the diagnosis and evaluation of cranial neuropathies</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><div class="content_para"><p>Positron emission tomography (PET) imaging used for evaluating head and neck malignancy may yield false positive findings in the larynx for patients with vocal cord paralysis or unrecognized physiological asymmetry.</p>
<p><strong><span style="text-decoration: underline;">Relative Radiation Level Information</span></strong></p>
<p>Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level (RRL) indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Patients in the pediatric age group are at inherently higher risk from exposure, both because of organ sensitivity and longer life expectancy (relevant to the long latency that appears to accompany radiation exposure). For these reasons, the RRL dose estimate ranges for pediatric examinations are lower as compared to those specified for adults. Additional information regarding radiation dose assessment for imaging examinations can be found in the American College of Radiology (ACR) Appropriateness Criteria&reg; Radiation Dose Assessment Introduction document (see the "Availability of Companion Documents" field).</p></div></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>The American College of Radiology (ACR) Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient's clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient's condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the U.S. Food and Drug Administration (FDA) have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination. </li>
    <li>ACR seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply individual or society endorsement of the final document. </li>
    <li>The views expressed in this manuscript are those of the author and do not reflect the official policy of the Department of Army/Navy/Air Force, Department of Defense, or United States Government. </li>
</ul></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Getting Better</p>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Policeni B, Burns J, Conley DB, Crowley RW, Harvey HB, Hoang J, Hunt CH, Jagadeesan BD, Juliano AF, Kennedy TA, Moonis G, Pannell JS, Patel ND, Perlmutter JS, Rosenow JM, Schroeder JW, Whitehead MT, Cornelius RS, Corey AS, Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria® cranial neuropathy. Reston (VA): American College of Radiology (ACR); 2017. 22 p.  [136 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2017</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>American College of Radiology - Medical Specialty Society</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>The American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria&reg;.</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Committee on Appropriateness Criteria, Expert Panel on Neurologic Imaging</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Panel Members</em>: Bruno Policeni, MD (<em>Principal Author and Panel Vice-chair</em>); Judah Burns, MD; David B. Conley, MD; R. Webster Crowley, MD; H. Benjamin Harvey, MD, JD; Jenny Hoang, MBBS; Christopher H. Hunt, MD; Bharathi D. Jagadeesan, MD; Amy F. Juliano, MD; Tabassum A. Kennedy, MD; Gul Moonis, MD; Jeffrey S. Pannell, MD; Nandini D. Patel, MD; Joel S. Perlmutter, MD; Joshua M. Rosenow, MD; Jason W. Schroeder, MD; Matthew T. Whitehead, MD; Rebecca S. Cornelius, MD (<em>Specialty Chair</em>); Amanda S. Corey, MD (<em>Panel Chair</em>)</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>All panel members, authors, and chairs must complete a Conflict of Interest and Expertise Survey annually, disclosing any actual or potential conflicts related to duties and responsibilities on the panel.</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: Wippold FJ II, Cornelius RS, Aiken AH, Angtuaco EJ, Berger KL, Brown DC, Davis PC, Holloway K, McConnell CT Jr, Mechtler LL, Nussenbaum B, Rosenow JM, Roth CJ, Seidenwurm DJ, Slavin K, Waxman AD, Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria&reg; cranial neuropathy. [online publication]. Reston (VA): American College of Radiology (ACR); 2012. 18 p. [130 references]</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f69509%2fNarrative%2f" title="ACR Web site">American College of Radiology (ACR) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>ACR Appropriateness Criteria&reg;. Overview. Reston (VA): American College of Radiology; 2015 Oct. 3 p. Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fOverview.pdf" title="ACR Web site">American College of Radiology (ACR) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Literature search process. Reston (VA): American College of Radiology; 2015 Feb. 1 p. Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fLiteratureSearchProcess.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Evidence table development. Reston (VA): American College of Radiology; 2015 Nov. 5 p. Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fEvidenceTableDevelopment.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Topic development process. Reston (VA): American College of Radiology; 2015 Nov. 2 p. Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fTopicDevelopmentProcess.pdf">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Rating round information. Reston (VA): American College of Radiology; 2015 Apr. 5 p. Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRatingRoundInfo.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Radiation dose assessment introduction. Reston (VA): American College of Radiology; 2017. 4 p. Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fACR%2fDocuments%2fAppCriteria%2fRadiationDoseAssessmentIntro.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Manual on contrast media. Reston (VA): American College of Radiology; 2017. 125 p. Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2fQuality-Safety%2fResources%2fContrast-Manual" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg;. Procedure information. Reston (VA): American College of Radiology; 2017 Mar. 4 p. Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2f%7e%2fmedia%2fE77E9964C8224151BE6D21A7CE68FEE4.pdf" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg; cranial neuropathy. Evidence table. Reston (VA): American College of Radiology; 2017. 34 p. Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f69509%2fEvidenceTable%2f" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>ACR Appropriateness Criteria&reg; cranial neuropathy. Literature search. Reston (VA): American College of Radiology; 2017. 2 p. Available from the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2facsearch.acr.org%2fdocs%2f69509%2fLitSearch%2f" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on December 10, 2010. This summary was updated by ECRI Institute on November 14, 2012. This summary was updated by ECRI Institute on June 23, 2017.</p>
<p>This NEATS assessment was completed by ECRI Institute on June 28, 2017. The information was verified by the guideline developer on July 25, 2017.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>Instructions for downloading, use, and reproduction of the American College of Radiology (ACR) Appropriateness Criteria&reg; may be found on the <a href="/web/20180713042756/https://www.guideline.gov/Home/Disclaimer?id=51005&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.acr.org%2fQuality-Safety%2fAppropriateness-Criteria%2fTermsConditions" title="ACR Web site">ACR Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180713042756im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180713042756/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180713042756/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180713042756/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180713042756/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180713042756/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180713042756/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180713042756/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713042756/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713042756/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713042756/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713042756/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180713042756/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180713042756/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180713042756/https://www.guideline.gov/disclaimer?id=51005&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180713042756im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180713042756/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180713042756/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180713042756/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180713042756/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180713042756/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180713042756/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180713042756/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180713042756/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180713042756/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180713042756/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180713042756/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180713042756/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180713042756/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180713042756/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180713042756/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180713042756/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180713042756/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180713042756/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180713042756/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180713042756im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180713042756/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180713042756im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180713042756im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180713042756/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180713042756/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180713042756js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180713042756js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 04:27:56 Jul 13, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 16:46:04 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 658.844 (3)
  esindex: 0.012
  captures_list: 679.265
  CDXLines.iter: 14.217 (3)
  PetaboxLoader3.datanode: 45.205 (4)
  exclusion.robots: 0.319
  exclusion.robots.policy: 0.301
  RedisCDXSource: 1.838
  PetaboxLoader3.resolve: 599.213
  load_resource: 26.741
-->